Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-03

FDA Approved: ARFORMOTEROL TARTRATE INHALATION SOLUTION — Original Application (Aucta Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original application for arformoterol tartrate inhalation solution, a generic inhaled long-acting beta-agonist for maintenance treatment of COP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARFORMOTEROL TARTRATE INHALATION SOLUTION (arformoterol tartrate inhalation solution)

Snippet

ORIG AP for ARFORMOTEROL TARTRATE INHALATION SOLUTION (ARFORMOTEROL TARTRATE)